US FDA approves Vertex’s non-opioid painkiller
By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals’ drug to treat acute pain, the health regulator said on Thursday, offering a first-of-its-kind alternative to addictive opioid painkillers that have fueled a national crisis. The oral drug, branded Journavx, works by blocking pain signals at their source, unlike opioids — …










